BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
9.24
+0.28 (3.13%)
Dec 20, 2024, 4:00 PM EST - Market closed
BrainsWay Revenue
BrainsWay had revenue of $10.50M in the quarter ending September 30, 2024, with 26.50% growth. This brings the company's revenue in the last twelve months to $38.63M, up 34.19% year-over-year. In the year 2023, BrainsWay had annual revenue of $31.79M with 16.96% growth.
Revenue (ttm)
$38.63M
Revenue Growth
+34.19%
P/S Ratio
n/a
Revenue / Employee
$288,291
Employees
134
Market Cap
173.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
Dec 31, 2019 | 23.10M | 6.70M | 40.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accuray | 444.20M |
Nektar Therapeutics | 93.14M |
Alector | 61.51M |
Nanobiotix | 45.22M |
Myomo | 25.24M |
Profound Medical | 8.98M |
Lyell Immunopharma | 63.00K |
BWAY News
- 9 days ago - BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder - GlobeNewsWire
- 4 weeks ago - BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewsWire
- 5 weeks ago - BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 7 weeks ago - BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 - GlobeNewsWire
- 2 months ago - BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea - GlobeNewsWire
- 2 months ago - BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners - GlobeNewsWire
- 3 months ago - BrainsWay Announces Significant Expansion on U.S. East Coast - GlobeNewsWire